Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Canadian Respiratory Journal
Volume 19, Issue 2, Pages 109-116
http://dx.doi.org/10.1155/2012/920918
Special Article

Alpha-1 Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Clinical Practice Guideline

DD Marciniuk,1 P Hernandez,2 M Balter,3 J Bourbeau,4 KR Chapman,4 GT Ford,5 JL Lauzon,5 F Maltais,6 DE O’Donnell,7 D Goodridge,1 C Strange,8 AJ Cave,9 K Curren,10 S Muthuri,10 and Canadian Thoracic Society COPD Clinical Assembly Alpha-1 Antitrypsin Deficiency Expert Working Group

1University of Saskatchewan, Saskatoon, Saskatchewan, Canada
2Dalhousie University, Halifax, Nova Scotia, Canada
3University of Toronto, Toronto, Ontario, Canada
4McGill University, Montreal, Quebec, Canada
5University of Calgary, Calgary, Alberta, Canada
6Laval University, Laval, Quebec, Canada
7Queen’s University, Kingston, Ontario, Canada
8Medical University of South Carolina, Charleston, South Carolina, USA
9University of Alberta, Edmonton, Alberta, Canada
10Canadian Thoracic Society, Ottawa, Ontario, Canada

Copyright © 2012 Canadian Thoracic Society. This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes.

Citations to this Article [52 citations]

The following is the list of published articles that have cited the current article.

  • Sarah K. Brode, Simon C. Ling, and Kenneth R. Chapman, “Alpha-1 antitrypsin deficiency: A commonly overlooked cause of lung disease,” Cmaj, vol. 184, no. 12, pp. 1365–1371, 2012. View at Publisher · View at Google Scholar
  • Peter A. Ricketti, David W. Unkle, John R. Vernaleo, Anthony J. Ricketti, and Dennis J. Cleri, “A 55-year-old man with severe persistent asthma poorly responsive to asthma therapy,” Allergy and Asthma Proceedings, vol. 33, no. 6, pp. 538–543, 2012. View at Publisher · View at Google Scholar
  • Maxime Lamontagne, Christian Couture, Dirkje S. Postma, Wim Timens, Don D. Sin, Peter D. Paré, James C. Hogg, David Nickle, Michel Laviolette, and Yohan Bossé, “Refining Susceptibility Loci of Chronic Obstructive Pulmonary Disease with Lung eqtls,” PLoS ONE, vol. 8, no. 7, pp. e70220, 2013. View at Publisher · View at Google Scholar
  • Alice M. Turner, “Alpha-1 Antitrypsin Deficiency: New Developments in Augmentation and Other Therapies,” BioDrugs, vol. 27, no. 6, pp. 547–558, 2013. View at Publisher · View at Google Scholar
  • H. Mal, “Déficit en alpha-1 antitrypsine,” Revue des Maladies Respiratoires Actualités, vol. 5, no. 4, pp. 291–292, 2013. View at Publisher · View at Google Scholar
  • F. de Serres, and I. Blanco, “Role of alpha-1 antitrypsin in human health and disease,” Journal of Internal Medicine, vol. 276, no. 4, pp. 311–335, 2014. View at Publisher · View at Google Scholar
  • Gary W. K. Wong, Marc Miravitlles, Alison Chisholm, and Jerry A. Krishnan, “Respiratory Guidelines—Which Real World?,” Annals of the American Thoracic Society, vol. 11, no. Supplement2, pp. S85–S91, 2014. View at Publisher · View at Google Scholar
  • Christine Waasdorp Hurtado, and Michael R. Narkewiczvol. 9781461490050, pp. 185–214, 2014. View at Publisher · View at Google Scholar
  • Andelo Beletić, Aleksandra Dudvarski-Ilić, Ljudmila Nagorni-Obradović, Mila Ljujić, Dragica Radojković, Branislava Milenković, Valentina Dordević, and Nada Majkić-Singh, “Alpha-1-antitrypsin deficiency - Molecular basis, clinical presentation, therapeutic options and an integrative approach in diagnostics,” Journal of Medical Biochemistry, vol. 33, no. 1, pp. 88–96, 2014. View at Publisher · View at Google Scholar
  • Andelo Beletić, Valentina Dordević, Aleksandra Dudvarski-Llić, Branislava Milenković, Ljudmila Nagorni-Obradović, Mila Ljujić, Dragica Radojković, and Nada Majkić-Singh, “Alpha-1-antitrypsin deficiency - Molecular basis, clinical presentation, therapeutic options and an integrative approach in diagnostics,” Journal of Medical Biochemistry, vol. 33, no. 1, pp. 88–96, 2014. View at Publisher · View at Google Scholar
  • Amit Banga, Haala Rokadia, and James K. Stoller, “A Review of Lung Transplantation for Patients With α-1 Antitrypsin Deficiency,” Clinical Pulmonary Medicine, vol. 22, no. 5, pp. 239–245, 2015. View at Publisher · View at Google Scholar
  • C E Green, S Vayalapra, J A Hampson, D Mukherjee, R A Stockley, and A M Turner, “PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD,” Thorax, vol. 70, no. 10, pp. 939–945, 2015. View at Publisher · View at Google Scholar
  • Timothy J. Craig, “Suspecting and Testing for Alpha-1 Antitrypsin Deficiency—An Allergist's and/or Immunologist's Perspective,” The Journal of Allergy and Clinical Immunology: In Practice, vol. 3, no. 4, pp. 506–511, 2015. View at Publisher · View at Google Scholar
  • Ana C. Bradi, Nadeen Audisho, Deborah K. Casey, and Kenneth R. Chapman, “Alpha-1 Antitrypsin Deficiency in Canada: Regional Disparities in Diagnosis and Management,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 12, no. sup1, pp. 15–21, 2015. View at Publisher · View at Google Scholar
  • Susan Sorrells, Sandra Camprubi, Rhonda Griffin, Junliang Chen, and Jaume Ayguasanosa, “SPARTA clinical trial design: Exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency,” Respiratory Medicine, vol. 109, no. 4, pp. 490–499, 2015. View at Publisher · View at Google Scholar
  • Francisco Casas, Ignacio Blanco, María Teresa Martínez, Ana Bustamante, Marc Miravitlles, Sergio Cadenas, José M. Hernández, Lourdes Lázaro, Esther Rodríguez, Francisco Rodríguez-Frías, María Torres, and Beatriz Lara, “Indications for Active Case Searches and Intravenous Alpha-1 Antitrypsin Treatment for Patients With Alpha-1 Antitrypsin Deficiency Chronic Pulmonary Obstructive Disease: An Update,” Archivos de Bronconeumología (English Edition), vol. 51, no. 4, pp. 185–192, 2015. View at Publisher · View at Google Scholar
  • Francisco Casas, Ignacio Blanco, María Teresa Martínez, Ana Bustamante, Marc Miravitlles, Sergio Cadenas, José M. Hernández, Lourdes Lázaro, Esther Rodríguez, Francisco Rodríguez-Frías, María Torres, and Beatriz Lara, “Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina,” Archivos de Bronconeumología, vol. 51, no. 4, pp. 185–192, 2015. View at Publisher · View at Google Scholar
  • J. Traclet, P. Delaval, P. Terrioux, and J.-F. Mornex, “Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema,” Revue des Maladies Respiratoires, vol. 32, no. 4, pp. 435–446, 2015. View at Publisher · View at Google Scholar
  • Palacios Gomez, Martin-Gomez, Martinez De La Plata, Hidalgo Rico, and Garcia-Marcos, “Administration of alpha-1 Antitrypsin in haemodialysis,” Clinical Practice, vol. 12, no. 1, pp. 1–4, 2015. View at Publisher · View at Google Scholar
  • Peter C Gøtzsche, and Helle Krogh JohansenCochrane Database of Systematic Reviews, 2016. View at Publisher · View at Google Scholar
  • Maria J. Chiuchiolo, and Ronald G. Crystal, “Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease,” Annals of the American Thoracic Society, vol. 13, no. Supplement_4, pp. S352–S369, 2016. View at Publisher · View at Google Scholar
  • Umur Hatipoğlu, and James K. Stoller, “α1-Antitrypsin Deficiency,” Clinics in Chest Medicine, 2016. View at Publisher · View at Google Scholar
  • C. E. Green, D. G. Parr, R. G. Edgar, R. A. Stockley, and A. M. Turner, “Lung density associates with survival in alpha 1 antitrypsin deficient patients,” Respiratory Medicine, vol. 112, pp. 81–87, 2016. View at Publisher · View at Google Scholar
  • Maria Paula Henao, and Timothy J. Craig, “Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency,” Expert Review of Respiratory Medicine, vol. 10, no. 12, pp. 1281–1294, 2016. View at Publisher · View at Google Scholar
  • Daniel Jacko, Rembert Andreas Koczulla, Marion Wencker, Tobias Welte, Wilhelm Bloch, Klaus Kenn, Inga Jarosch, Sebastian Gehlert, and Sabina Janciauskiene, “Different training-induced skeletal muscle adaptations in COPD patients with and without alpha-1 antitrypsin deficiency,” Respiration, vol. 92, no. 5, pp. 339–347, 2016. View at Publisher · View at Google Scholar
  • Rodrigo Russo, Laura Russo Zillmer, Oliver Augusto Nascimento, Beatriz Manzano, Ivan Teruaki Ivanaga, Leandro Fritscher, Fernando Lundgren, Marc Miravitlles, Heicilainy Del Carlos Gondim, Gildo Santos Junior, Marcela Amorim Alves, Maria Vera Oliveira, Altay Alves Lino de Souza, Maria Penha Uchoa Sales, and José Roberto Jardim, “Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil,” Jornal Brasileiro de Pneumologia, vol. 42, no. 5, pp. 311–316, 2016. View at Publisher · View at Google Scholar
  • Reena Berman, Di Jiang, Qun Wu, and Hong Wei Chu, “alpha 1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke,” International Journal Of Chronic Obstructive Pulmonary Disease, vol. 11, pp. 1279–1286, 2016. View at Publisher · View at Google Scholar
  • Krzysztof Karuś, Agata Dzeljilji, and Wojciech Rokicki, “Selected metabolic aspects of elastin and collagen fiber proteolysis in diseases of the respiratory system - The significance of α1 antitrypsin deficiency,” Kardiochirurgia i Torakochirurgia Polska, vol. 13, no. 3, pp. 242–247, 2016. View at Publisher · View at Google Scholar
  • Ying Chen, Shu-Yi Zhu, Zhuo-Chao Zhou, Wen-Qi Shen, and Ai-Wu Zhou, “Research progress of α1-antitrypsin deficiency of mutant Z,” Journal of Shanghai Jiaotong University (Medical Science), vol. 37, no. 8, pp. 1179–1183, 2017. View at Publisher · View at Google Scholar
  • Kalliopi Aggelou, and Nikolaos Siafakas, “Medical lung volume reduction for severe emphysema: A review,” Respiratory Medicine, 2017. View at Publisher · View at Google Scholar
  • Inga Jarosch, Wolfgang Hitzl, Andreas Rembert Koczulla, Marion Wencker, Tobias Welte, Rainer Gloeckl, Sabina Janciauskiene, and Klaus Kenn, “Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency,” Respiratory Medicine, 2017. View at Publisher · View at Google Scholar
  • David G. Parr, and Beatriz Lara, “Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: A review of the current literature,” Drug Design, Development and Therapy, vol. 11, pp. 2149–2162, 2017. View at Publisher · View at Google Scholar
  • Eric Lessard, Heather M. Young, Anurag Bhalla, Damien Pike, Khadija Sheikh, David G. McCormack, Alexei Ouriadov, and Grace Parraga, “Pulmonary 3 He Magnetic Resonance Imaging Biomarkers of Regional Airspace Enlargement in Alpha-1 Antitrypsin Deficiency,” Academic Radiology, 2017. View at Publisher · View at Google Scholar
  • Sayyed Gholamreza Mortazavimoghaddam, Reza Eslami Manoochehri, Mahmod Zardast, and Mohammad Hasan Namaei, “Alterationsinserum Antitrypsin Level and Its Association with Pulmonary Complications Among Patients with Lung Tuberculosis,” Modern Care Journal, vol. InPress, no. InPress, 2017. View at Publisher · View at Google Scholar
  • Silvano Dragonieri, Giorgio Pennazza, Pierluigi Carratu, and Onofrio Resta, “Electronic Nose Technology in Respiratory Diseases,” Lung, vol. 195, no. 2, pp. 157–165, 2017. View at Publisher · View at Google Scholar
  • Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Darcy D. Marciniuk, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D'Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Denis E. O'Donnell, and Don D. Sin, “CTS position statement: Pharmacotherapy in patients with COPD—An update,” Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, vol. 1, no. 4, pp. 222–241, 2017. View at Publisher · View at Google Scholar
  • Jan Stolk, Alice Turner, Asger Dirksen, Vladimir Koblizek, Ravi Mahadeva, Marc Miravitlles, Nicolas Roche, Gabriel Thabut, Claus Vogelmeier, Robert A. Stockley, Ilaria Ferrarotti, Peter Lange, Noel G. McElvaney, David Parr, and Eeva Piitulainen, “European Respiratory Society statement: Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency,” European Respiratory Journal, vol. 50, no. 5, 2017. View at Publisher · View at Google Scholar
  • A. Gillissen, Christian M. Kähler, A. Rembert Koczulla, Rüdiger Sauer, and Maria Paparoupa, “Aktuelle Therapieoptionen bei der COPD,” MMW - Fortschritte der Medizin, vol. 159, no. S3, pp. 32–43, 2017. View at Publisher · View at Google Scholar
  • Timm Greulich, Christoph Nell, Marco Grebe, Sabina Janciauskiene, David Hohmann, Andreas Rembert Koczulla, and Claus Franz Vogelmeier, “The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: Results from a large population-based database,” European Respiratory Journal, vol. 49, no. 1, 2017. View at Publisher · View at Google Scholar
  • Ignacio Blanco, “Alpha-1 Antitrypsin Deficiency: Introduction and History,” Blanco's Overview of Alpha-1 Antitrypsin Deficiency, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Ignacio Blanco, “Clinical Management and Treatment of Lung Disease,” Blanco's Overview of Alpha-1 Antitrypsin Deficiency, pp. 175–191, 2017. View at Publisher · View at Google Scholar
  • María Torres-Durán, José Luis Lopez-Campos, Miriam Barrecheguren, Marc Miravitlles, Beatriz Martinez-Delgado, Silvia Castillo, Amparo Escribano, Adolfo Baloira, María Mercedes Navarro-Garcia, Daniel Pellicer, Lucía Bañuls, María Magallón, Francisco Casas, and Francisco Dasí, “Alpha-1 antitrypsin deficiency: outstanding questions and future directions,” Orphanet Journal of Rare Diseases, vol. 13, no. 1, 2018. View at Publisher · View at Google Scholar
  • Timothy J. Craig, and Maria Paula Henao, “ Advances in managing COPD related to α 1 -antitrypsin deficiency: An under-recognized genetic disorder ,” Allergy, 2018. View at Publisher · View at Google Scholar
  • Article Editorial, “Diagnosis and treatment of pulmonarydisease in α1-antitrypsin deficiency: a statement of European Respiratory Society,” Russian Pulmonology, vol. 28, no. 3, pp. 273–295, 2018. View at Publisher · View at Google Scholar
  • Anne B. Chang, and Gregory J. Reddingpp. 439–459.e6, 2018. View at Publisher · View at Google Scholar
  • Leonor Meira, Rita Boaventura, Susana Seixas, and Maria Sucena, “Alpha-1 Antitrypsin Deficiency Detection in a Portuguese Population,” COPD: Journal of Chronic Obstructive Pulmonary Disease, pp. 1–6, 2018. View at Publisher · View at Google Scholar
  • François Maltais, Nathalie Gaudreault, Christine Racine, Sébastien Thériault, and Yohan Bossé, “ Clinical Experience with SERPINA1 DNA Sequencing to Detect Alpha-1 Antitrypsin Deficiency ,” Annals of the American Thoracic Society, vol. 15, no. 2, pp. 266–268, 2018. View at Publisher · View at Google Scholar
  • A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira, and L. Telo, “Portuguese consensus document for the management of alpha-1-antitrypsin deficiency,” Pulmonology, vol. 24, pp. 1–21, 2018. View at Publisher · View at Google Scholar
  • Kristen E. Holm, David M. Mannino, Radmila Choate, and Robert A. Sandhaus, “Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease,” Respiratory Medicine, vol. 143, pp. 48–55, 2018. View at Publisher · View at Google Scholar
  • James K. Stoller, “The Challenge of Rare Diseases,” Chest, 2018. View at Publisher · View at Google Scholar
  • A Rembert Koczulla, Kenneth R. Chapman, Joanna Chorostowska-Wynimko, Ilaria Ferrarotti, and Noel G. McElvaney, “Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: Recent developments and clinical implications,” International Journal of COPD, vol. 13, pp. 419–432, 2018. View at Publisher · View at Google Scholar
  • Wilke, Grohé, Semper, and Gross, “Longterm Homecare Augmentation Program in Alpha-1-Antitrypsin Deficient Patients,” Pneumologie, vol. 72, no. 8, pp. 590–597, 2018. View at Publisher · View at Google Scholar